CoChat

Nanomedicine in treatment of breast cancer – A challenge to conventional therapy

Afzal, Muhammad, Ameeduzzafar, Alharbi, Khalid Saad, Alruwaili, Nabil K, Al-Abassi, Fahad A., Al-Malki, Abdulrahman Al Labeed, Kazmi, Imran, Kumar, Vikas, Kamal, Mohammad Amjad, Nadeem, Muhammad Shahid, Aslam, Muhammad, Anwar, Firoz · 2021 · Seminars in Cancer Biology
Cited by 123

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

Amongst the various types of cancer, breast cancer is a highly heterogeneous disease and known as the leading cause of death among women globally. The extensive interdisciplinary investigation in nanotechnology and cancer biomedical research has been evolved over the years for its effective treatment. However, the advent of chemotherapeutic resistance in breast cancer is one of the major confront researchers are facing in achieving successful chemotherapy. Research in the area of cancer nanotechnology over the years have now been revolutionized through the development of smart polymers, lipids, inorganic materials and eventually their surface-engineering with targeting ligands. Moreover, nanotechnology further extended and brings in the notice the new theranostic approach which combining the therapy and imaging simultaneously. Currently, research is being envisaged in the area of novel nano-pharmaceutical design viz. liposome, nanotubes, polymer lipid hybrid system, which focuses to make the chemotherapy curative and long-lasting. In this review, we aimed to discuss the recent advancement of different surface-engineered/targeted nanomedicines that improved the drug efficacy in breast cancer.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.semcancer.2019.12.016

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 179

  1. Siersbak, 2018, Signaling pathways and steroid receptors modulating estrogen receptor α function in breast cancer, Genes Dev., 32, 1141, 10.1101/gad.316646.118 · DOI
  2. Kohler, 2015, Annual report to the nation on the status of cancer, 1975– 2011, featuring incidence of breast cancer subtypes by race/ ethnicity, poverty, and state, J. Natl. Cancer Inst., 107, 10.1093/jnci/djv048 · DOI · Paper page
  3. Golubnitschaja, 2016, Breast cancer epidemic in the early 21st century: evaluation of risk factors, cumulative questionnaires and recommendations for preventive measures, J. Immunother. Emphasis Tumor Immunol., 37, 12941
  4. Youn, 2018, Perspectives on the past, present, and future of cancer nanomedicine, Adv. Drug Deliv. Rev., 130, 3, 10.1016/j.addr.2018.05.008 · DOI · Paper page
  5. El-Sawy, 2018, Stimuli-responsive nano-architecture drug-delivery systems to solid tumor micromilieu: past, present, and future perspectives, ACS Nano, 12, 10636, 10.1021/acsnano.8b06104 · DOI · Paper page
  6. Ma, 2019, Atorvastatin inhibits breast Cancer cells by downregulating PTEN/AKT pathway via PromotingRas homolog family member B (RhoB), Biomed Res. Int., 2019, 10.1155/2019/3235021 · DOI
  7. Barron, 2008, Assessing the economic burden of breast cancer in a US managed care population, Breast Cancer Res. Treat., 109, 367, 10.1007/s10549-007-9650-4 · doi:10.1007/s10549-007-9650-4
  8. Zucchetti, 2019, The role of histone deacetylase inhibitors in metastatic breast cancer, Breast., 43, 130, 10.1016/j.breast.2018.12.001 · DOI
  9. Daniel, 2016, Recent advances in the medical treatment of breast cancer, Version F1000Res., 5, 2786, 10.12688/f1000research.9619.1 · DOI
  10. D. Mei, B. Chen, B. He, H. Liu, Z. Lin, J. Lin, X. Zhang, N. Sun, L. Zhao, X. Wang, Q. Zhang, Actively priming autophagic cell death with novel transferrin receptor-targeted nanomedicine for synergistic chemotherapy against breast cancer. Acta Pharmaceutica Sinica B. https://doi.org/10.1016/j.apsb.2019.03.006. · DOI
  11. Hare, 2017, Challenges and strategies in anti-cancer nanomedicine development: an industry perspective, Adv. Drug Deliv. Rev., 108, 25, 10.1016/j.addr.2016.04.025 · DOI · Paper page
  12. Sang, 2018, Multifunctional hyaluronic acid-decorated redox-responsive magnetic complex micelle for targeted drug delivery with enhanced antitumor efficiency and anti-cell-Migration activity, J. Biomed. Nanotechnol., 14, 477, 10.1166/jbn.2018.2541 · DOI
  13. Peng, 2019, Nanoparticles promote in vivo breast cancer cell intravasation and extravasation by inducing endothelial leakiness, Nat. Nanotechnol., 14, 279, 10.1038/s41565-018-0356-z · DOI · Paper page
  14. Shi, 2017, Cancer nanomedicine: progress, challenges and opportunities, Nat. Rev. Cancer, 17, 20, 10.1038/nrc.2016.108 · DOI · Paper page
  15. Xie, 2019, Challenges and opportunities from basic Cancer biology for nanomedicine for targeted drug delivery, Curr. Cancer Drug Targets, 19, 257, 10.2174/1568009618666180628160211 · DOI
  16. Avitabile, 2018, How can nanotechnology help the fight against breast cancer?, Nanoscale, 10, 11719, 10.1039/C8NR02796J · DOI
  17. Mahmoodzadeh, 2018, A novel gold-based stimuli-responsive theranostic nanomedicine for chemo-photothermal therapy of solid tumors, Mater. Sci. Eng. C Mater. Biol. Appl., 93, 880, 10.1016/j.msec.2018.08.067 · DOI
  18. Juneja, 2019, Multimodal polysilsesquioxane nanoparticles for combinatorial therapy and gene delivery in triple-negative breast Cancer, ACS Appl. Mater. Interfaces, 11, 12308, 10.1021/acsami.9b00704 · DOI · Paper page
  19. Matsumura, 1986, A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs, Cancer Res., 46, 6387
  20. Gerlowski, 1986, Microvascular permeability of normal and neoplastic tissues, Microvasc. Res., 31, 288, 10.1016/0026-2862(86)90018-X · DOI · Paper page
  21. Sang, 2018, A novel redox/pH dual-responsive and hyaluronic acid-decorated multifunctional magnetic complex micelle for targeted gambogic acid delivery for the treatment of triple negative breast cancer, Drug Deliv., 25, 1846, 10.1080/10717544.2018.1486472 · DOI
  22. Weiss, 2013, First-in-human phase 1/2a trial of CRLX101, a cyclodextrin-containing polymer-camptothecin nanopharmaceutical in patients with advanced solid tumor malignancies Investig, New Drugs., 31, 986, 10.1007/s10637-012-9921-8 · DOI · Paper page
  23. Ashton, 2016, Aurora kinase inhibitor nanoparticles target tumors with favorable therapeutic index in vivo, Sci. Transl. Med., 8, 10.1126/scitranslmed.aad2355 · DOI · Paper page
  24. Allahverdiyev, 2018, Current aspects in treatment of breast cancer based of nanodrug delivery systems and future prospects, Artif. Cells Nanomed. Biotechnol., 46, S755, 10.1080/21691401.2018.1511573 · DOI · Paper page
  25. Akhter, 2018, Nanocarriers in advanced drug targeting: setting novel paradigm in cancer therapeutics, Artif. Cells Nanomed. Biotechnol., 46, 873, 10.1080/21691401.2017.1366333 · DOI
  26. Yi, 2019, Glucose-linked sub-50-nm unimer polyion complex-assembled gold nanoparticles for targeted siRNA delivery to glucose transporter 1-overexpressing breast cancer stem-like cells, J. Control. Release, 295, 268, 10.1016/j.jconrel.2019.01.006 · DOI · Paper page
  27. Adil. Allahverdiyev, 2018, Current aspects in treatment of breast cancer based of nanodrug delivery systems and future prospects, Artif. Cells Nanomed. Biotechnol., 46, S755, 10.1080/21691401.2018.1511573 · DOI · Paper page
  28. Yewale, 2018, Docetaxel loaded immunonanoparticles delivery in EGFR over expressed breast carcinoma cells, J. Drug Deliv. Sci. Technol., 45, 334, 10.1016/j.jddst.2018.03.027 · DOI
  29. Sneider, 2017, Engineering remotely triggered liposomes to target triple negative breast cancer, Oncomedicine., 2, 1, 10.7150/oncm.17406 · DOI
  30. Pillai, 2019, Applications of targeted nano drugs and delivery systems. Chapter 9 - nanotechnology toward treating cancer: a comprehensive review, 221
  31. Cao, 2019, Direct nucleus-targeted drug delivery using cascade pHe /Photo dual-sensitive polymeric nanocarrier for Cancer therapy, Small., 18
  32. Zhou, 2019, Multifunctional nanoparticles based on a polymeric copper chelator for combination treatment of metastatic breast cancer, Biomaterials., 195, 86, 10.1016/j.biomaterials.2019.01.007 · DOI
  33. Liu, 2018, Targeting 17q23 amplicon to overcome the resistance to anti HER2 therapy in HER2+ breast cancer, Nat. Commun., 9, 4718, 10.1038/s41467-018-07264-0 · DOI
  34. Zheng, 2019, Improving breast cancer therapy using doxorubicin loaded solid lipid nanoparticles: synthesis of a novel arginine-glycine-aspartic tripeptide conjugated, pH sensitive lipid and evaluation of the nanomedicine in vitro and in vivo, Biomed. Pharmacother., 116, 10.1016/j.biopha.2019.109006 · DOI · Paper page
  35. Legut, 2014, Anacardic acid enhances the anticancer activity of liposomal mitoxantrone towards melanoma cell lines - in vitro studies, Int. J. Nanomedicine, 9, 653
  36. Yingchoncharoen, 2016, Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come, Pharmacol. Rev., 68, 701, 10.1124/pr.115.012070 · DOI · Paper page
  37. Vail, 2004, Pegylated liposomal doxorubicin: proof of principle using preclinical animal models and pharmacokinetic studies, Semin. Oncol., 31, 16, 10.1053/j.seminoncol.2004.08.002 · DOI · Paper page
  38. Zhao, 2019, Dual-active targeting liposomes drug delivery system for bone metastatic breast cancer: synthesis and biological evaluation, Chem. Phys. Lipids, 223, 10.1016/j.chemphyslip.2019.104785 · DOI
  39. Samson, 2019, Liposomal co-delivery-based quantitative evaluation of chemosensitivity enhancement in breast cancer stem cells by knockdown of GRP78/CLU, J. Liposome Res., 29, 44, 10.1080/08982104.2017.1420081 · DOI
  40. Jiang, 2018, Enhanced antitumor and anti-metastasis efficacy against aggressive breast cancer with a fibronectin-targeting liposomal doxorubicin, J. Control. Release, 271, 21, 10.1016/j.jconrel.2017.12.026 · DOI
  41. Mrugala, 2019, Phase II study of systemic high-dose methotrexate and intrathecal liposomal cytarabine for treatment of leptomeningeal carcinomatosis from breast Cancer, Clin. Breast Cancer, 18
  42. Schneeweiss, 2019, Eur. J. Cancer, 106, 181, 10.1016/j.ejca.2018.10.015 · DOI
  43. Xia, 2018, Losartan loaded liposomes improve the antitumor efficacy of liposomal paclitaxel modified with pH sensitive peptides by inhibition of collagen in breast cancer, Pharm. Dev. Technol., 23, 13, 10.1080/10837450.2016.1265553 · DOI
  44. Cai, 2011, Lymphatic drug delivery using engineered liposomes and solid lipid nanoparticles, Adv. Drug Deliv. Rev., 63, 901, 10.1016/j.addr.2011.05.017 · DOI · Paper page
  45. Siram, 2014, Solid lipid nanoparticles of diethylcarbamazine citrate for enhanced delivery to the lymphatics: in vitro and in vivo evaluation, Expert Opin. Drug Deliv., 11, 1351, 10.1517/17425247.2014.915310 · DOI
  46. Jain, 2019, Beta-carotene-Encapsulated solid lipid nanoparticles (BC-SLNs) as promising vehicle for Cancer: an investigative assessment, AAPS PharmSciTech, 20, 100, 10.1208/s12249-019-1301-7 · DOI
  47. Xu, 2018, Enhanced anticancer activity and intracellular uptake of paclitaxel-containing solid lipid nanoparticles in multidrug-resistant breast cancer cells, Int. J. Nanomedicine, 13, 7549, 10.2147/IJN.S182621 · DOI
  48. Siddhartha, 2018, RAGE receptor targeted bioconjuguate lipid nanoparticles of diallyl disulfide for improved apoptotic activity in triple negative breast cancer: in vitro studies, Artif. Cells Nanomed. Biotechnol., 46, 387, 10.1080/21691401.2017.1313267 · DOI
  49. Zhang, 2019, Biodegradable hybrid mesoporous silica nanoparticles for gene/chemo-synergetic therapy of breast cancer, J. Biomater. Appl., 33, 1382, 10.1177/0885328219835490 · DOI
  50. Eskiler, 2018, Solid lipid nanoparticles: reversal of tamoxifen resistance in breast cancer, Eur. J. Pharm. Sci., 120, 73, 10.1016/j.ejps.2018.04.040 · DOI
  51. Jadon, 2019, Docetaxel-loaded lipid-polymer hybrid nanoparticles for breast cancer therapeutics, J. Drug Deliv. Sci. Technol., 51, 475, 10.1016/j.jddst.2019.03.039 · DOI
  52. Varshosaz, 2018, Docetaxel-loaded nanostructured lipid carriers functionalized with trastuzumab (Herceptin) for HER2-positive breast cancer cells, J. Liposome Res., 28, 285, 10.1080/08982104.2017.1370471 · DOI
  53. Agrawal, 2018, CD44 targeting hyaluronic acid coated lapatinib nanocrystals foster the efficacy against triple-negative breast cancer, Nanomedicine, 14, 327, 10.1016/j.nano.2017.10.010 · DOI
  54. Chen, 2019, Indocyanine green/doxorubicin-encapsulated functionalized nanoparticles for effective combination therapy against human MDR breast cancer, Colloids Surf B Biointerfaces, 177, 294, 10.1016/j.colsurfb.2019.02.001 · DOI
  55. Du, 2019, Polymer-lipid hybrid nanoparticles: a novel drug delivery system for enhancing the activity of Psoralen against breast cancer, Int. J. Pharm., 561, 274, 10.1016/j.ijpharm.2019.03.006 · DOI
  56. Soe, 2019, Transferrin-conjugated polymeric nanoparticle for receptor-mediated delivery of doxorubicin in doxorubicin-resistant breast Cancer cells, Pharmaceutics., 11, 10.3390/pharmaceutics11020063 · DOI
  57. Yuan, 2018, pH-sensitive polymeric nanoparticles of mPEG-PLGA-PGlu with hybrid core for simultaneous encapsulation of curcumin and doxorubicin to kill the heterogeneous tumour cells in breast cancer, Artif. Cells Nanomed. Biotechnol., 46, 302, 10.1080/21691401.2017.1423495 · DOI
  58. Hu, 2018, Redox-sensitive folate-conjugated polymeric nanoparticles for combined chemotherapy and photothermal therapy against breast Cancer, J. Biomed. Nanotechnol., 14, 2018, 10.1166/jbn.2018.2647 · DOI
  59. Chandra, 2014, Advances in preparation and characterization of chitosan nanoparticles for therapeutics, Artif. Cells Nanomed. Biotechnol., 44, 305, 10.3109/21691401.2014.948548 · DOI
  60. Ebrahimi, 2016, Novel drug delivery system based on doxorubicin encapsulated magnetic nanoparticles modified with PLGA-PEG1000 copolymer, Artif. Cells Nanomed. Biotechnol., 44, 290, 10.3109/21691401.2014.944646 · DOI
  61. Niu, 2019, A novel chitosan-based nanomedicine for multi-drug resistant breast cancer therapy, Chem. Eng. J., 369, 134, 10.1016/j.cej.2019.02.201 · DOI
  62. Abou-El-Naga, 2018, Activation of polymeric nanoparticle intracellular targeting overcomes chemodrug resistance in human primary patient breast cancer cells, Int. J. Nanomedicine, 13, 8153, 10.2147/IJN.S182184 · DOI
  63. DeVeaux, 2019, Assessing the potential of Chitosan/Polylactide nanoparticles for delivery of therapeutics for triple-negative breast Cancer treatment, Regen. Eng. Transl. Med., 5, 61, 10.1007/s40883-018-0089-4 · DOI
  64. Bressler, 2018, Biomimetic peptide display from a polymeric nanoparticle surface for targeting and antitumor activity to human triple-negative breast cancer cells, J. Biomed. Mater. Res. Part B Appl. Biomater., 106A, 1753, 10.1002/jbm.a.36360 · DOI
  65. Nosrati, 2018, PAMAM-modified citric acid-coated magnetic nanoparticles as pH sensitive biocompatible carrier against human breast cancer cells, Drug Dev. Ind. Pharm., 44, 1377, 10.1080/03639045.2018.1451881 · DOI
  66. Nicolas, 2018, Polymeric nanocapsules as drug carriers for sustained anticancer activity of calcitriol in breast cancer cells, Int. J. Pharm., 550, 170, 10.1016/j.ijpharm.2018.08.022 · DOI
  67. Enteshari, 2018, Antitumor activity of raloxifene-targeted poly (styrene maleic acid)-poly (amide-ether-ester-imide) co-polymeric nanomicelles loaded with docetaxel in breast cancer-bearing mice, Invest. New Drugs, 36, 206, 10.1007/s10637-017-0533-1 · DOI
  68. Yang, 2018, A positron emission tomography image-guidable unimolecular micelle nanoplatform for cancer theranostic applications, Acta Biomater., 79, 306, 10.1016/j.actbio.2018.08.036 · DOI
  69. Kutlehria, 2018, Cholecalciferol-PEG conjugate based nanomicelles of doxorubicin for treatment of triple-negative breast Cancer, AAPS PharmSciTech, 19, 792, 10.1208/s12249-017-0885-z · DOI
  70. Baidya, 2019, Chrysin-loaded folate conjugated PF127-F68 mixed micelles with enhanced oral bioavailability and anticancer activity against human breast cancer cells, Drug Dev. Ind. Pharm., 45, 852, 10.1080/03639045.2019.1576726 · DOI
  71. Pawar, 2019, Development of fisetin-loaded folate functionalized pluronic micelles for breast cancer targeting, Artif Cells Nanomed Biotechnol, 46 sup1, 347
  72. Farrokhi, 2018, Delivery of DNAzyme targeting c-Myc gene using β-cyclodextrin polymer nanocarrier for therapeutic application in human breast cancer cell line, J. Drug Deliv. Sci. Technol., 47, 477, 10.1016/j.jddst.2018.08.015 · DOI
  73. Rodriguez-Razon, 2018, Adhesion, proliferation, and apoptosis in different molecular portraits of breast cancer treated with silver nanoparticles and its pathway-network analysis, Int. J. Nanomedicine, 13, 1081, 10.2147/IJN.S152237 · DOI
  74. Gurunathan, 2015, Comparative assessment of the apoptotic potential of silver nanoparticles synthesized by Bacillus tequilensis and Calocybe indica in MDA-MB-231 human breast cancer cells: targeting p53 for anticancer therapy, Int. J. Nanomed., 10, 4203, 10.2147/IJN.S83953 · DOI · Paper page
  75. Jin, 2018, Theranostics of triple-negative breast Cancer Based on conjugated polymer nanoparticles, ACS Appl. Mater. Interfaces, 10, 10634, 10.1021/acsami.7b14603 · DOI
  76. Garcia, 2018, Targeted photodynamic therapy of breast cancer cells using lactose-phthalocyanine functionalized gold nanoparticles, J. Colloid Interface Sci., 512, 249, 10.1016/j.jcis.2017.10.030 · DOI
  77. Chowdhury, 2019, Tannic acid-inspired paclitaxel nanoparticles for enhanced anticancer effects in breast cancer cells, J. Colloid Interface Sci., 535, 133, 10.1016/j.jcis.2018.09.072 · DOI · Paper page
  78. Kamaruzman, 2019, Oncogenic signaling in Tumorigenesis and applications of siRNA nanotherapeutics in breast Cancer, Cancers (Basel)., 11, 10.3390/cancers11050632 · DOI
  79. Nunez, 2018, Inorganic nanoparticles in diagnosis and treatment of breast cancer, J. Biol. Inorg. Chem., 23, 331, 10.1007/s00775-018-1542-z · DOI
  80. Mahendran, 2018, Coumarin–gold nanoparticle bioconjugates: preparation, antioxidant, and cytotoxic effects against MCF-7 breast cancer cells, Appl. Nanosci., 8, 447, 10.1007/s13204-018-0816-7 · doi:10.1007/s13204-018-0816-7
  81. Nosrati, 2017, Methotrexate-conjugated L-lysine coated iron oxide magnetic nanoparticles for inhibition of MCF-7 breast cancer cells, Drug Dev. Ind. Pharm., 27, 1
  82. Nosrati, 2018, Anticancer activity of tamoxifen loaded tyrosine decorated biocompatible Fe3O4 magnetic nanoparticles against breast Cancer cell lines, JIOPM., 28, 1178
  83. Manatunga, 2018, Effective delivery of hydrophobic drugs to breast and liver cancer cells using a hybrid inorganic nanocarrier: a detailed investigation using cytotoxicity assays, fluorescence imaging and flow cytometry, Eur. J. Pharm. Biopharm., 128, 18, 10.1016/j.ejpb.2018.04.001 · DOI
  84. Jin, 2019, Near-infrared light-regulated cancer theranostic nanoplatform based on aggregation-induced emission luminogen encapsulated upconversion nanoparticles, Theranostics., 9, 246, 10.7150/thno.30174 · DOI
  85. Sinha, 2005, Carbon nanotubes for biomedical applications, IEEE Trans Nanobiosci., 4, 180, 10.1109/TNB.2005.850478 · DOI · Paper page
  86. Fabbro, 2012, Targeting carbon nanotubes against cancer, Chem. Commun. (Camb.), 48, 3911, 10.1039/c2cc17995d · DOI · Paper page
  87. Liu, 2019, Hyaluronic acid-coated single-walled carbon nanotubes loaded with doxorubicin for the treatment of breast cancer, Pharmazie., 74, 83
  88. Moreira, 2016, Stimuli-responsive mesoporous silica nanoparticles for cancer therapy: a review, Microporous Mesoporous Mater., 236, 141, 10.1016/j.micromeso.2016.08.038 · DOI · Paper page
  89. Feng, 2016, The application of mesoporous silica nanoparticle family in cancer theranostics, Coord. Chem. Rev., 319, 86, 10.1016/j.ccr.2016.04.019 · DOI · Paper page
  90. Zhou, 2018, Mesoporous silica nanoparticles for drug and gene delivery, Acta Pharm. Sin. B, 8, 165, 10.1016/j.apsb.2018.01.007 · DOI · Paper page
  91. Freitas, 2017, Multifunctional mesoporous silica nanoparticles for cancer-targeted, controlled drug delivery and imaging, Microporous Mesoporous Mater., 242, 271, 10.1016/j.micromeso.2017.01.036 · DOI
  92. Wang, 2018, Stimuli-responsive nanocarrier for Co-delivery of MiR-31 and doxorubicin to suppress high MtEF4 Cancer, ACS Appl. Mater. Interfaces, 10, 22767, 10.1021/acsami.8b07698 · DOI
  93. Li, 2018, Actively Targeted Deep Tissue Imaging and Photothermal-Chemo Therapy of Breast Cancer by Antibody-Functionalized Drug-Loaded X-Ray-Responsive Bismuth Sulfide@Mesoporous Silica Core-Shell Nanoparticles, Adv. Funct. Mater., 28
  94. Zayed, 2019, Hybrid quantum dot-based theranostic nanomedicines for tumor-targeted drug delivery and cancer imaging, Nanomedicine Lond. (Lond), 14, 225, 10.2217/nnm-2018-0414 · doi:10.2217/nnm-2018-0414
  95. Kefayat, 2019, Investigation of different targeting decorations effect on the radiosensitizing efficacy of albumin-stabilized gold nanoparticles for breast cancer radiation therapy, Eur. J. Pharm. Sci., 130, 225, 10.1016/j.ejps.2019.01.037 · DOI · Paper page
  96. Dalmina Pittella F, 2019, Magnetically responsive hybrid nanoparticles for in vitro siRNA delivery to breast cancer cells, Mater. Sci. Eng. C Mater. Biol. Appl., 99, 1182, 10.1016/j.msec.2019.02.026 · DOI
  97. Munster, 2018, Safety and pharmacokinetics of MM-302, a HER2-targeted antibody-liposomal doxorubicin conjugate, in patients with advanced HER2-positive breast cancer: a phase 1 dose-escalation study, Br. J. Cancer, 119, 1086, 10.1038/s41416-018-0235-2 · DOI · Paper page
  98. Jain, 2019, Dendrimer mediated targeting of siRNA against polo-like kinase for the treatment of triple negative breast cancer, J. Biomed. Mater. Res. A., 107, 1933, 10.1002/jbm.a.36701 · doi:10.1002/jbm.a.36701
  99. H. Qiao, Z. Zhu, D. Fang, Y. Sun, C. Kang, L. Di, L. Zhang, Y. Gao. Redox-triggered mitoxantrone prodrug micelles for overcoming multidrug-resistant breastcancer. J Drug Target. 26(1) 201875-201885. · DOI
  100. Xiong, 2018, Primary tumor and pre-metastatic niches co-targeting "peptides-lego" hybrid hydroxyapatite nanoparticles for metastatic breast cancer treatment, Biomater. Sci., 6, 2591, 10.1039/C8BM00706C · DOI
  101. Zhang, 2017, Dual-targeted hybrid nanoparticles of synergistic drugs for treating lung metastases of triple negative breast cancer in mice, Acta Pharmacol. Sin., 38, 835, 10.1038/aps.2016.166 · DOI
  102. Kushwah, 2018, Co-delivery of docetaxel and gemcitabine by anacardic acid modified self-assembled albumin nanoparticles for effective breast cancer management, Acta Biomater., 73, 424, 10.1016/j.actbio.2018.03.057 · DOI
  103. Tang, 2018, Enhanced delivery of siRNA to triple negative breast cancer cells in vitro and in vivo through functionalizing lipid-coated calcium phosphate nanoparticles with dual target ligands, Nanoscale, 10, 4258, 10.1039/C7NR08644J · DOI · Paper page
  104. Wu, 2019, A strategy using mesoporous polymer nanospheres as nanocarriers of Bcl-2 siRNA towards breast cancer therapy, J. Mater. Chem. B Mater. Biol. Med., 7, 477, 10.1039/C8TB02463D · DOI
  105. Vandghanooni, 2018, Recent advances in aptamer-armed multimodal theranostic nanosystems for imaging and targeted therapy of cancer, Eur. J. Pharm. Sci., 117, 301, 10.1016/j.ejps.2018.02.027 · DOI
  106. Ramirez-Garcia, 2018, An immuno -conjugated up-conversion nanocomplex for selective imaging and photodynamic therapy against HER2-positive breast cancer, Nanoscale., 10, 10154, 10.1039/C8NR01512K · DOI
  107. Pan, 2018, Theranostic pH-sensitive nanoparticles for highly efficient targeted delivery of doxorubicin for breast tumor treatment, Int. J. Nanomedicine, 13, 1119, 10.2147/IJN.S147464 · DOI
  108. Liu, 2019, Theranostic nanoparticles with tumor-specific enzyme-triggered size reduction and drug release to perform photothermal therapy for breast cancer treatment, Acta Pharm. Sin. B, 9, 410, 10.1016/j.apsb.2018.09.001 · DOI · Paper page
  109. Barabadi, 2019, Emerging theranostic biogenic silver nanomaterials for breast Cancer: a systematic review, J. Clust. Sci., 30, 259, 10.1007/s10876-018-01491-7 · DOI
  110. Yao, 2016, Ligand-targeted theranostic nanomedicines against cancer, J. Control. Release, 240, 267, 10.1016/j.jconrel.2016.01.002 · DOI · Paper page
  111. Valizadeh, 2012, Quantum dots: synthesis, bioapplications, and toxicity, Nanoscale Res. Lett., 7, 480, 10.1186/1556-276X-7-480 · DOI · Paper page
  112. Volsi, 2018, Hybrid Gold/Silica/Quantum-dots supramolecular-nanostructures encapsulated in polymeric micelles as potential theranostic tool for targeted cancer therapy, Eur. Polym. J., 105, 38, 10.1016/j.eurpolymj.2018.05.013 · DOI
  113. Olerile, 2017, Near-infrared mediated quantum dots and paclitaxel co-loaded nanostructured lipid carriers for cancer theragnostic, Colloids Surf. B Biointerfaces, 150, 121, 10.1016/j.colsurfb.2016.11.032 · DOI
  114. Yang, 2015, Facile synthesis of Gd-Cu-In-S/ZnS bimodal quantum dots with optimized properties for tumor targeted fluorescence/MR in vivo imaging, ACS Appl. Mater. Interfaces, 7, 18759, 10.1021/acsami.5b05372 · DOI
  115. Ghosh, 2019, Vol. 373, 468
  116. Kim, 2019, Anti-EGF receptor aptamer-guided Co-delivery of anti-cancer siRNAs and quantum dots for theranostics of triple-negative breast Cancer, Eranostics., 9, 837
  117. Liu, 2018, 2D superparamagnetic tantalum carbide composite MXenes for efficient breast-cancer theranostics, Theranostics., 8, 1648, 10.7150/thno.23369 · DOI · Paper page
  118. Zafar, 2019, Novel therapeutic interventions in cancer treatment using protein and peptide-based targeted smart systems, Semin. Cancer Biol.
  119. Ahmadzada, 2018, Fundamentals of siRNA and miRNA therapeutics and a review of targeted nanoparticle delivery systems in breast cancer, Biophys. Rev., 10, 10.1007/s12551-017-0392-1 · DOI · Paper page
  120. Rahman, 2017, Therapeutic applications of liposomal based drug delivery and drug targeting for immune linked inflammatory maladies: a contemporary view point, Curr. Drug Targets, 18, 1558, 10.2174/1389450118666170414113926 · DOI
  121. Deng, 2014, Hyaluronic acid-chitosan nanoparticles for co-delivery of MiR-34a and doxorubicin in therapy against triple negative breast cancer, Biomaterials, 35, 4333, 10.1016/j.biomaterials.2014.02.006 · DOI · Paper page
  122. Rahman, 2019, Vol. 26, 629
  123. Juneja, 2019, Multimodal polysilsesquioxane nanoparticles for combinatorial therapy and gene delivery in triple-negative breast Cancer, ACS Appl. Mater. Interfaces, 11, 12308, 10.1021/acsami.9b00704 · DOI · Paper page
  124. Pandey, 2018, Implication of nano-antioxidant therapy for treatment of hepatocellular carcinoma using PLGA nanoparticles of rutin, Nanomedicine Lond. (Lond), 13, 849, 10.2217/nnm-2017-0306 · DOI
  125. Jafari, 2019, Anti-Mucin1 aptamer-conjugated chitosan nanoparticles for targeted Co-delivery of Docetaxel and IGF-1R siRNA to SKBR3 metastatic breast Cancer cells, Iran. Biomed. J., 23, 21, 10.29252/ibj.23.1.21 · DOI
  126. Beg, 2017, Nanoporous metal organic frameworks as hybrid polymer-metal composites for drug delivery and biomedical applications, Drug Discov. Today, 22, 625, 10.1016/j.drudis.2016.10.001 · DOI · Paper page
  127. Cai, 2018, Enzyme-sensitive biodegradable and multifunctional polymeric conjugate as theranostic nanomedicine, Applied medicine today., 11, 207
  128. Rajendrakumar, 2018, Dual-stimuli-responsive albumin-polyplex nanoassembly for spatially controlled gene release in metastatic breast cancer, J. Control. Release, 276, 72, 10.1016/j.jconrel.2018.02.039 · DOI
  129. Karahaliloglu, 2018, Enhanced antitumor activity of epigallocatechin gallate– conjugated dual-drug-loaded polystyrene–polysoyaoil– diethanol amine nanoparticles for breast cancer therapy, J. Bioact. Compat. Polym., 33, 38, 10.1177/0883911517710811 · DOI
  130. Ghassami, 2019, HER-2 aptamer-targeted Ecoflex® nanoparticles loaded with docetaxel promote breast cancer cells apoptosis and anti-metastatic effect, IET Nanobiotechnol., 13, 428, 10.1049/iet-nbt.2018.5047 · DOI
  131. Wang, 2018, Indocyanine green-incorporating nanoparticles for cancer theranostics, Theranostics., 8, 1227, 10.7150/thno.22872 · DOI · Paper page
  132. Sang, 2018, Magnetic and CD44 receptor dual targeting redox-responsive polymeric micelle for precise delivery of Gambogic acid to triple-negative breast cancer, AJPS
  133. Zhang, 2019, Chemotherapy drugs derived nanoparticles encapsulating mRNA encoding tumor suppressor proteins to treat triple-negative breast cancer, Nano Res., 12, 855, 10.1007/s12274-019-2308-9 · DOI · Paper page
  134. Majidi N, 2018, Targeted Co-delivery of Docetaxel and cMET siRNA for treatment of Mucin1 overexpressing breast Cancer cells, Adv. Pharm. Bull., 8, 383, 10.15171/apb.2018.045 · DOI
  135. Ni, 2018, In situ shRNA synthesis on DNA-Polylactide nanoparticles to treat multidrug resistant breast Cancer, Adv Mater, 30
  136. Parhi, 2015, Trastuzumab guided nanotheranostics: a lipid based multifunctional nanoformulation for targeted drug delivery and imaging in breast cancer therapy, J. Colloid Interface Sci., 451, 198, 10.1016/j.jcis.2015.03.049 · DOI
  137. Truffi, 2018, Multivalent exposure of trastuzumab on iron oxide nanoparticles improves antitumor potential and reduces resistance in HER2-positive breast cancer cells, Sci. Rep., 8, 6563, 10.1038/s41598-018-24968-x · DOI
  138. Bonizzi, 2019, Everolimus nanoformulation in biological nanoparticles increases drug responsiveness in resistant and low-responsive breast Cancer cell lines, Pharmaceutics., 11, E384, 10.3390/pharmaceutics11080384 · DOI
  139. Mazzucchelli, 2017, H-Ferritin-nanocaged olaparib: a promising choice for both BRCA-mutated and sporadic triple negative breast cancer, Sci. Rep., 7, 7505, 10.1038/s41598-017-07617-7 · DOI
  140. Dalmina, 2019, Magnetically responsive hybrid nanoparticles for in vitro siRNA delivery to breast cancer cells, Mater. Sci. Eng. C Mater. Biol. Appl., 99, 1182, 10.1016/j.msec.2019.02.026 · DOI
  141. Lee, 2019, Mitochondria targeting and destabilizing hyaluronic acid derivative-based nanoparticles for the delivery of lapatinib to triple-negative breast Cancer, Biomacromolecules., 20, 835, 10.1021/acs.biomac.8b01449 · DOI
  142. Zajdel, 2019, Cytotoxic effect of paclitaxel and lapatinib Co-delivered in polylactide-co-Poly(ethylene glycol) micelles on HER-2-Negative breast Cancer cells, Pharmaceutics., 11, E169, 10.3390/pharmaceutics11040169 · DOI
  143. Beg, 2019, Nanomedicinal strategies as efficient therapeutic interventions for delivery of cancer vaccines, Semin. Cancer Biol.
  144. Kong, 2018, Polydopamine-functionalized CA-(PCL-ran-PLA) nanoparticles for target delivery of docetaxel and chemo-photothermal therapy of breast Cancer, Front. Pharmacol., 9, 125, 10.3389/fphar.2018.00125 · DOI
  145. Liu, 2019, Theranostic nanoparticles with tumor-specific enzyme-triggered size reduction and drug release to perform photothermal therapy for breast cancer treatment, Acta Pharm. Sin. B, 9, 410, 10.1016/j.apsb.2018.09.001 · DOI · Paper page
  146. Meng, 2019, Effect of chitosan based glycolipid-like nanocarrier in prevention of developing acquired drug resistance in tri-cycle treatment of breast cancer, Int J Pharma., 555, 303, 10.1016/j.ijpharm.2018.11.056 · DOI
  147. Li, 2018, α-Lipoic acid stabilized DTX/IR780 micelles for photoacoustic/fluorescence imaging guidedphotothermal therapy/chemotherapy of breast cancer, Biomater. Sci., 6, 1201, 10.1039/C8BM00096D · DOI
  148. Martínez-Jothar, 2019, Selective Cytotoxicity to HER2 Positive Breast Cancer Cells by Saporin-Loaded Nanobody-Targeted Polymeric Nanoparticles in Combination with Photochemical Internalization, J. Mol. Pharm. Org. Process Res., 16, 1633
  149. Wang, 2019, Sequentially self-assembled polysaccharide-based nanocomplexes for combined chemotherapy and photodynamic therapy of breast cancer, Carbohydr. Polym., 203, 203, 10.1016/j.carbpol.2018.09.035 · DOI
  150. Aneja, 2014, Cancer targeted magic bullets for effective treatment of cancer, Recent Pat. Antiinfect. Drug Discov., 9, 121, 10.2174/1574891X10666150415120506 · DOI · Paper page
  151. Liu, 2018, Dual pH-responsive multifunctional nanoparticles for targeted treatment of breast cancer by combining immunotherapy and chemotherapy, Acta Biomater., 66, 310, 10.1016/j.actbio.2017.11.010 · DOI · Paper page
  152. Guney Eskiler, 2018, Solid lipid nanoparticles: Reversal of tamoxifen resistance in breast cancer, Eur. J. Pharm. Sci., 120, 73, 10.1016/j.ejps.2018.04.040 · DOI
  153. Rahman, 2016, Emergence of liposome as targeted magic bullet for inflammatory disorders: current state of the art, Artif. Cells Nanomed. Biotechnol., 44, 1597, 10.3109/21691401.2015.1129617 · DOI
  154. Souto, 2019, Surface-tailored anti-HER2/neu-solid lipid nanoparticles for site-specific targeting MCF-7 and BT-474 breast cancer cells, Eur. J. Pharm. Sci., 128, 27, 10.1016/j.ejps.2018.11.022 · DOI
  155. Zheng, 2019, Improving breast cancer therapy using doxorubicin loaded solid lipid nanoparticles: synthesis of a novel arginine-glycine-aspartic tripeptide conjugated, pH sensitive lipid and evaluation of the nanomedicine in vitro and in vivo, Biomed. Pharmacother., 116, 10.1016/j.biopha.2019.109006 · DOI · Paper page
  156. Yang, 2018, A cancer cell turn-on protein-CuSMn nanoparticle as the sensor of breast cancer cell and CH3O-PEG-phosphatide, Chinese Chem. Lett., 29, 1528, 10.1016/j.cclet.2018.02.011 · doi:10.1016/j.cclet.2018.02.011
  157. Kefayat, 2019, Investigation of different targeting decorations effect on the radiosensitizing efficacy of albumin-stabilized gold nanoparticles for breast cancer radiation therapy, Eur. J. Pharm. Sci., 130, 225, 10.1016/j.ejps.2019.01.037 · DOI · Paper page
  158. Rezaei, 2018, NanoMIL-100(Fe) containing docetaxel for breast cancer therapy, Artif. Cells Nanomed. Biotechnol., 46, 1390, 10.1080/21691401.2017.1369425 · DOI
  159. García Calavia, 2018, Targeted photodynamic therapy of breast cancer cells using lactose-phthalocyanine functionalized gold nanoparticles, J. Colloid Interface Sci., 512, 249, 10.1016/j.jcis.2017.10.030 · DOI
  160. Hou, 2019, A novel pH-sensitive targeting polysaccharide-gold nanorod conjugate for combined photothermal-chemotherapy of breast cancer, Carbohydr. Polym., 212, 334, 10.1016/j.carbpol.2019.02.045 · DOI
  161. Graham-Gurysh, 2018, Hybrid donor-acceptor polymer particles with amplified energy transfer for detection and on-demand treatment of breast Cancer, ACS Appl. Mater. Interfaces, 10, 7697, 10.1021/acsami.7b19503 · DOI
  162. Ahmad, 2014, Transformation of curcumin from food additive to multifunctional medicine: nanotechnology bridging the gap, Curr. Drug Discov. Technol., 11, 197, 10.2174/1570163811666140616153436 · DOI
  163. Baneshi, 2019, A novel theranostic system of AS1411 aptamer-functionalized albumin nanoparticles loaded on iron oxide and gold nanoparticles for doxorubicin delivery, Int. J. Pharm., 564, 145, 10.1016/j.ijpharm.2019.04.025 · DOI
  164. Akhter, 2011, Cancer targeted metallic nanoparticle: targeting overview, recent advancement and toxicity concern, Curr. Pharm. Des., 17, 1834, 10.2174/138161211796391001 · DOI
  165. Zhan, 2019, DNA-based nanomedicine with targeting and enhancement of therapeutic efficacy of breast Cancer cells, ACS Appl. Mater. Interfaces, 11, 15354, 10.1021/acsami.9b03449 · DOI
  166. Nguyen, 2019, Folate receptor-targeted liposomal nanocomplex for effective synergistic photothermal-chemotherapy of breast cancer in vivo, Colloids Surf. B Biointerfaces, 173, 539, 10.1016/j.colsurfb.2018.10.013 · DOI
  167. Yi, 2019, Glucose-linked sub-50-nm unimer polyion complex-assembled gold nanoparticles for targeted siRNA delivery to glucose transporter 1-overexpressing breast cancer stem-like cells, J. Control. Release, 295, 268, 10.1016/j.jconrel.2019.01.006 · DOI · Paper page
  168. Rizwanullah, 2019, Polymer-lipid hybrid systems: scope of intravenous-to-Oral switch in Cancer chemotherapy, Curr. Nanomed., 9, 1
  169. Talamantez-Lyburn, 2019, Gold nanoparticles loaded with cullin-5 DNA increase sensitivity to 17-AAG in cullin-5 deficient breast cancer cells, Int. J. Pharm., 564, 281, 10.1016/j.ijpharm.2019.04.022 · DOI
  170. Gajendiran, 2019, Green synthesis of multifunctional PEG-carboxylate π back-bonded gold nanoconjugates for breast cancer treatment, Int. J. Nanomedicine, 14, 819, 10.2147/IJN.S190946 · DOI
  171. Vinothini, 2019, Folate receptor targeted delivery of paclitaxel to breast cancer cells via folic acid conjugated graphene oxide grafted methyl acrylate nanocarriers, Biomed. Pharmacother., 110, 906, 10.1016/j.biopha.2018.12.008 · DOI
  172. Ahmad, 2010, Metallic nanoparticles: technology overview & drug delivery applications in oncology, Expert Opin. Drug Deliv., 7, 927, 10.1517/17425247.2010.498473 · DOI · Paper page
  173. Yu, 2018, Antitumor effects of carbon nanotube-drug complex against human breast cancer cells, Exp. Ther. Med., 16, 1103, 10.3892/etm.2016.3444 · DOI
  174. A. Oskoueian, K. A. Matori,S. Bayat, E. Oskoueian, F. Ostovan, M. Toozandehjani, Fabrication, Characterization, and Functionalization of Single-Walled Carbon Nanotube Conjugated with Tamoxifen and Its Anticancer Potential against Human Breast Cancer Cells, Journal of Nanomaterials. doi.org/10.1155/2018/8417016. · DOI
  175. Vemuri, 2019, Novel biosynthesized gold nanoparticles as anti-cancer agents against breast cancer: Synthesis, biological evaluation, molecular modelling studies, Mater. Sci. Eng. C Mater. Biol. Appl., 99, 417, 10.1016/j.msec.2019.01.123 · doi:10.1016/j.msec.2019.01.123
  176. Yuan, 2018, pH-sensitive polymeric nanoparticles of mPEG-PLGA-PGlu with hybrid core for simultaneous encapsulation of curcumin and doxorubicin to kill the heterogeneous tumour cells in breast cancer, Artif. Cells Nanomed. Biotechnol., 46, 302, 10.1080/21691401.2017.1423495 · DOI
  177. Abedin, 2018, Polymer coated gold-ferric oxide superparamagnetic nanoparticles for theranostic applications, J. Nanobiotechnology, 16, 80, 10.1186/s12951-018-0405-7 · DOI
  178. Beg, 2018, In: chapter 4 - emergence in the functionalized carbon nanotubes as smart nanocarriers for drug delivery applications, 105
  179. Du, 2019, Polymer-lipid hybrid nanoparticles: A novel drug delivery system for enhancing the activity of Psoralen against breast cancer, Int. J. Pharm., 561, 274, 10.1016/j.ijpharm.2019.03.006 · DOI

Cited by

See all 123

Metadata

Authors
Afzal, M., Ameeduzzafar, Alharbi, K. S., Alruwaili, N. K., Al-Abassi, F. A., Al-Malki, A. A. L., Kazmi, I., Kumar, V., Kamal, M. A., Nadeem, M. S., Aslam, M., & Anwar, F.
Venue
Seminars in Cancer Biology
Publisher
Elsevier BV
Published
2021-02
Volume
69
Pages
279-292
ISSN
1044-579X (ISSN-L)
OpenAlex
W2995027661
Cited by
123
References
7
FWCI
2.91
Type
journal article
Language
en
Open access
closed
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.